Spedali Civili di Brescia Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
1993
NCT00002529
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Barbara Borroni | Spedali Civili Brescia | Spedali Civili di Brescia, Brescia - Italy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aspergillosis (Phase 2)

Breast Neoplasms (Phase 3)

Infections (Phase 2)

Invasive Pulmonary Aspergillosis (Phase 2)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Precancerous Conditions (Phase 2)

Pulmonary Aspergillosis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 31